Program
ceftobiprole
Also written as “Ceftobiprole” and “pitavastatin single dose combined with ceftobiprole”.
Its studies are mostly in Staphylococcal Skin Infections · Obesity · Pneumonia, Ventilator-Associated, led by Basilea Pharmaceutica.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Basilea Pharmaceutica | 80 open or running | phase 1since Oct 9, 2008 | Oct 9, 2008 | none ahead |
Also a collaborator on its studies: Johnson & Johnson.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Oct 9, 2008First studies: 2 phase 1 studiesFirst studyNCT00771719, NCT00771524
- Aug 21, 2009Phase 1 study in Antimicrobial AgentNCT00965042 · 12 enrolled
- Dec 3, 20094 phase 1 studiesNCT01026740, NCT01026636, NCT01026558 and 1 more
- Jan 9, 2025Phase 1 study in Drug-drug Interaction StudyNCT06808646 · 12 enrolled · Netherlands
TargetBeta
A vaccine: it acts on a pathogen, not a human gene.
“Bacterial penicillin-binding protein inhibitor”ChEMBL 37, by rule
Studies
All 8 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06808646Drug-drug Interaction Study · Netherlands | 1 | Completed | Feb 25, 2025 | 12 |
| NCT01030731Staphylococcal Skin Infections | 1 | Completed | Aug 2007 | 12 |
| NCT01026740Staphylococcal Skin Infections | 1 | Completed | Sep 2007 | 15 |
| NCT01026636Staphylococcal Skin Infections | 1 | Completed | Apr 2010 | 64 |
| NCT01026558Obesity | 1 | Completed | Nov 2007 | 25 |
| NCT00965042Antimicrobial Agent | 1 | Completed | May 2009 | 12 |
| NCT00771524Total Hip Replacement Surgery | 1 | Completed | Feb 2010 | 22 |
| NCT00771719Pneumonia, Ventilator-Associated | 1 | Terminated | Nov 2009 | 1 |
How it is read
Names in the registry
- “Ceftobiprole”, 7 entries
- “pitavastatin single dose combined with ceftobiprole”, 1 entry
Conditions, from the studies’ own filings
- Staphylococcal Skin Infections, 3 studies
- Obesity, 1 study
- Pneumonia, Ventilator-Associated, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.